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ABSTRACT
Objectives: Exposure to chromium, the transition element found in many compounds of earth’s crust, leads to various health hazards including 
cancer, dermatitis, damage of liver and kidneys, and reproductive toxicity in both male and female. Toxic effect of chronic exposure to chromium at 
low environmentally relevant dose is recently recognized and less studied. In the present study, we evaluated the effect of subchronic exposure to low 
doses of chromium VI (K2Cr2O7) on various hematological and biochemical parameters in male albino rats.
Methods: Male albino rats (160±10 g) received 1/25, 1/50, and 1/100 of reported oral LD50 dose of chromium VI (K2Cr2O7) for 90 consecutive days. 
After treatment, the blood was collected for analysis of various hematological and biochemical parameters.
Results: Exposure to chromium VI at 1/25 LD50 dose caused decrease in body weight gain and reduction in the weight of the reproductive organs 
along with increase in the weight of the liver and kidney. Numbers of red blood cells, white blood cells, platelets, and hemoglobin concentration 
reduced with increase in clotting time. The total sperm count and motility was also reduced in exposed rats. There was a decrease in plasma protein 
and albumin concentration, with increase in plasma glucose and cholesterol level. The activity of enzyme alanine aminotransferase and enzyme 
aspartate aminotransferase was stimulated in treated rats.
Conclusion: The results of the present study revealed that chronic low-dose exposure to chromium VI resulted in a toxic effect in experimental male 
albino rats.
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INTRODUCTION
Chromium is one of the major environmental toxicants that affect 
human health. It is one among the eight most common pollutant 
heavy metals listed by the Environmental Protection Agency [1]. It is 
a naturally occurring element found in rocks, volcanic dust and gasses, 
soils as well as plants and animals. This transition metal can exist in 
various oxidized forms ranging from −2 to +6. The three main oxidation 
forms of chromium, commonly found in the workplace and general 
environment, are chromium (0), chromium (III), and chromium (VI). 
Chromium (0) is the metal chromium, a steel-gray solid with a high 
melting point usually used for making steel and other alloys. Chromium 
(III) and chromium (VI) compounds are widely used industrially in 
stainless steel production, welding, electroplating, leather tanning, 
production of dyes and pigments, and wood preservatives [2,3]. It is well 
known that oral intake along with food and water is the major route of 
exposure to chromium for the general population. It has been reported 
that the chromium (VI) form appears to be 10-100 times more toxic 
than the chromium (III) form when both are administered by the oral 
route [4]. Chromium (VI) can easily enter the cell than chromium (III) 
through SO42- and PO42- channels. After entering the cell, chromium (VI) 
undergoes a chain reaction with production of chromium intermediates 
such as chromium (V) and chromium (IV) by cellular reductants such 
as ascorbic acid and riboflavin, glutathione, and serum protein [5]. 
The reduced product binds to intracellular proteins, resulting in 
an elevation of total chromium in the blood cell for several weeks. 
During this reduction process, chromium produces reactive oxygen 
species and generates oxidative stress. This in turn is responsible for 
defective hematopoiesis [6]. It has been reported that chromium (VI) 
is considered as a toxic transition heavy metal and a potent industrial 
hazard that causes severe damage to a variety of tissues and organs 
including the reproductive system [7-10]. Most of the studies on toxic 
effects of chromium involve a dose much higher than the amount of 
chromium available in drinking water and within the permissible limit 
set by the World Health Organization [11]. The effect of subchronic 
exposure to chromium at low environmentally relevant dose level is not 
well established. Therefore, in the present study, we investigated the 
effect of chronic exposure to chromium in low concentration on various 
hematological and biochemical parameters in male albino rats.
METHODS
Chemicals and drugs
Potassium dichromate (K2Cr2O7) was purchased from Merck Specialities 
Pvt. Ltd., Mumbai, India. Magnesium chloride, sodium hydroxide, 
sodium p-nitrophenol, citric acid, and sodium citrate were obtained 
from Sisco Research Laboratories Pvt. Ltd. The commercial kits such 
as glucose kit, total cholesterol kit, urea kit, creatinine kit, total protein 
kit, albumin kit, enzyme alanine aminotransferase kit, and aspartate 
aminotransferase kit were purchased from Coral Clinical System, India.
Animals
Twenty-four adult male Wistar rats (70±10 days) weighing 170±10 g 
were used in the present study. The animals were housed in 
polypropylene cages in the institutional animal house under controlled 
condition of temperature (25±2°C) and normal day/night schedule 
(12 L:12 D). Animals were fed on standardized normal diet which 
consists of wheat and gram in 1:1 ratio, salt, sugar, milk, and water 
ad libitum. The entire study protocol was approved by the Institutional 
Animal Ethical Committee (IAEC).
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Study design
The rats are equally divided into four groups consisting of six rats 
per group. The animals of different groups received treatment orally 
through gavages for 90 days as follows:
• Group I - Control group - Distilled water 2 ml/day.
• Group II - Treated Group I - K2Cr2O7 - 0.25 mg/kg bw/day.
• Group III - Treated Group II - K2Cr2O7 - 0.5 mg/kg bw/day.
• Group IV - Treated Group III - K2Cr2O7 - 1 mg/kg bw/day.
The doses of the drug were determined according to the median value 
of reported oral LD50 dose [12].
Animal sacrifice
At the end of treatment period, animals were sacrificed by cervical 
dislocation following ether anesthesia. Utmost care was taken during 
the time of sacrifice according to the Indian Council of Medical Research 
guidelines [13].
Body weight and organ weight
The body weight was recorded on the first day of treatment (initial), on 
the interval of every 15 days, and on the day of sacrifice (final). The liver, 
kidney, testicles, and accessory sex organs, namely, seminal vesicles, 
ventral prostate, and cauda epididymis were dissected out and trimmed 
of the attached tissues and weighed. The relative weight of organs was 
expressed per 100 g of body weight to ensure normalization of data for 
statistical analysis.
Hematological studies
The fresh blood was collected in heparinized test tubes; some of the 
blood was centrifuged at 3000 rpm to obtain the serum, which was kept 
frozen at −20°C until used for further analysis.
The other blood was used to determine the hematological parameters 
such as hemoglobin concentration, red blood cell (RBC) count, white 
blood cell (WBC) count, platelet count, and clotting time using the 
standard procedures.
Biochemical studies from serum
The serum glucose was measured by the glucose oxidase-
peroxidase/peroxidase oxidase-peroxidase method. The serum 
cholesterol was measured by the cholesterol oxidase/peroxidase 
aminophena method. The serum urea was measured by the modified 
Berthelot method. The serum creatinine was measured by the modified 
Jaffe’s Kinetic method. The serum protein was measured by the biuret 
method. The serum albumin was measured by the bromocresol green 
method. The serum glutamic pyruvic transaminase and serum glutamic 
oxaloacetic transaminase were measured by Reitman and Frankel 
method.
Sperm count and sperm motility
Sperm samples were collected from the cauda epididymis. Sperm count 
and motility was determined by hemocytometer following the method 
of Majumder and Biswas [14]. These two parameters were expressed as 
a percentage of total sperms.
Data analysis
Data were analyzed using statistical software StatPro for Windows, 
version 11.0. Mean and SE values for each parameters in different groups 
were calculated. A post hoc t-test was performed to compare the differences 
between means. A statistically significance value was set at p<0.05.
RESULTS
Effect on body weight
Table 1 represents percentage gain of body weight and relative organ 
weight in control and different treatment groups. The body weight gain 
reduced significantly in treatment Group III.
Effect on organ weight
There was a significant increase in the weight of the liver and kidney in 
treated animals. Weight of the heart and spleen varied insignificantly 
between the groups. There was a decrease in relative weight of testes 
and epididymis and increase in the weight of other accessory organs 
after treatment with potassium dichromate for 90 days in treatment 
Group III (Table 1).
Effect on hematological parameters
Hematological study showed a significant decrease in hemoglobin 
concentration along with increase in counts of RBC, WBC, and platelet in 
animals of treatment Group III. The clotting time increased significantly 
in animals of this group (Table 2).
Effect on biochemical parameters
Biochemical analysis represented in Table 3 showed a significant 
decrease in plasma protein and albumin level in chromium-treated 
animals. Plasma glucose, cholesterol, urea, creatinine, enzyme 
alanine aminotransferase, and aspartate aminotransferase increased 
significantly in animals of treatment Group III.
Table 1: Change in body weight and organ weight in male rats following exposure to chromium for 90 days
Parameter Control 
group (6)
Treatment Group I (6) Treatment Group II (6) Treatment Group III (6)
Body weight gain (%) 44.82±1.58 42.86±1.75 41.69±1.37 33.89±0.02*
Weight of liver (g/100 bw) 4.39±0.08 4.38±0.08 4.42±0.07 6.18±0.01*
Weight of kidney (g/100 bw) 1.46±0.05 1.46±0.03 1.50±0.03 1.84±0.09*
Weight of heart (g/100 bw) 0.59±0.01 0.60±0.07 0.57±0.01 0.63±0.01
Weight of spleen (g/100 bw) 1.24±0.07 1.30±0.02 1.29±0.16 1.10±0.06
Weight of testes (g/100 bw) 1.33±0.02 1.31±0.02 1.27±0.06 1.02±0.06*
Weight of epididymis (mg/100 bw) 165.87±1.17 161.53±2.09 160.66±2.46 127.08±0.01*
Weight of seminal vesicles (mg/100 bw) 170.35±3.09 164.48±3.34 162.18±4.20 149.56±0.01*
Weight of prostate (mg/100 bw) 63.23±1.77 60.46±2.18 59.13±1.71 52.28±0.01*
Weight of bulbourethral gland (mg/100 bw) 207.93±4.67 199.08±6.33 195.60±5.03 178.29±0.02*
Values are in mean±SE. Number in parenthesis indicates number of animal in each group. *p<0.05
Table 2: Effect of treatment with hexavalent chromium on hematological parameters of the animal
Animal (6) Hb (g/dl) RBC count (106/µl) WBC count (103/µl) Platelet count (103/µl) Clotting time (min)
Control group (6) 13.48±0.23 6.07±0.06 7.95±0.16 743.99±8.09 5.05±0.03
Treatment Group I (6) 13.37±0.28 5.87±0.12 7.48±0.28 694.11±22.28 5.38±0.18
Treatment Group II (6) 12.90±0.15 5.73±0.05 7.37±0.23 678.76±24.13 5.45±0.15
Treatment Group III (6) 9.80±0.01* 3.80±0.01* 4.60±0.01* 554.69±0.01* 7.95±0.01*
Values are in mean±SE. Number in parenthesis indicates number of animal in each group. *p<0.05, RBC: Red blood cell, WBC: White blood cell
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Effect on sperm count and motility
There was a significant decrease in sperm count and motility in 
treatment Group III after potassium dichromate treatment in male rats 
(Table 4).
DISCUSSION
The effect of chronic exposure to potassium dichromate on body 
weight gain and on the weight of the vital organs liver and kidney, in 
our study, revealed that there was a significant decrease in body weight 
gain at highest dose along with an increase in relative weights of the 
liver and kidney. This indicated that chronic treatment with potassium 
dichromate resulted in a general toxic effect in the animals. The increase 
in the weight of the liver and kidney coupled with decrease in body 
weight gain due to chronic exposure to chromium at low-dose level 
indicates general toxic effect of such exposure on male rats [15]. This 
suggested that chronic chromium exposure resulted in a nutritional 
disturbance in treated rats [16]. Chandra et al. observed similar 
decline in body weight gain after exposure to potassium dichromate for 
26 days [17].
From our observation, it can be seen that treatment with potassium 
dichromate induces anemia type of condition with decreased RBC 
count and hemoglobin concentration. Earlier reports revealed that 
chromium exposure to rats resulted in reduction of RBC count and 
hematocrit value along with a decrease in hemoglobin concentration. 
The decrease in hemoglobin appears to be due to inhibition of its 
biosynthesis by decreasing the succinyl pool as well as glycine pool [18]. 
In this study, along with decreased RBC count, there was also decrease 
in WBC and platelet count. This might due to generalized injury caused 
to the hematopoietic stem cells by chromium treatment [19]. Similar 
disruption in hemopoietic mechanisms was observed by Adjroud after 
potassium dichromate exposure in both male and female rats [20].
The biochemical analysis in this study showed an increase in 
activities of enzymes alanine aminotransferase, enzyme aspartate 
aminotransferase, creatinine, and urea nitrogen level with a decline in 
protein and albumin levels. This indicated general and systemic toxic 
effect of heavy metals on male rats [21]. Increase in plasma glucose and 
cholesterol level in this study might be due to less utilization of these 
nutrients at tissue level [22].
The results of the study revealed that chronic treatment of potassium 
dichromate for 90 days at a dose three times to 1/50 of LD50 dose 
resulted in decrease in the weight of testes and epididymis and increase 
in the weight of prostate and seminal vesicles in male rats. Similar 
observation on the effect of hexavalent chromium on male reproductive 
system has been reported by several authors. Marouani et al. observed 
a similar effect on reproductive organs of male rats after intraperitoneal 
injection of potassium dichromate (1 or 2 mg/kg bw) for 15 consecutive 
days [23]. Chandra et al. observed uniform decline in weight of testes 
and other accessory male sex organs after chromium (VI) treatment in 
male rats [17]. These observations are corroborated with a decrease in 
number and motility of sperm in this study.
CONCLUSION
The study revealed that low subchronic treatment with potassium 
dichromate (Chromium VI) resulted in general toxicity in male albino 
rats.
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